Relmada Therapeutics, Inc. (RLMD)

7.03 +0.69 (+10.88%) USD  |  NASDAQ  |  May 19, 16:00
7.035 0.00 (0.00%) After-Hours: 20:00
More

Relmada Therapeutics EV to Free Cash Flow

EV to Free Cash Flow Chart

View EV to Free Cash Flow for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Free Cash Flow Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Free Cash Flow Range, Past 5 Years

View EV to Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Free Cash Flow Benchmarks

View EV to Free Cash Flow Benchmarks
Start Trial
Theravance Biopharma, Inc. Upgrade
AN2 Therapeutics, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
Johnson & Johnson Upgrade

EV to Free Cash Flow Related Metrics

EV to CFO Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade